Joshua Kiernan has extensive experience advising Israeli companies on Securities and Exchange Commission (SEC)-registered IPOs, follow-on and secondary offerings, block trades, private placements and Rule 144A offerings. In addition, his practice includes advising on a variety of debt offerings (including high yield and sovereign bonds) and cross-border M&A, joint ventures, and leveraged buyouts.
Mr. Kiernan assists clients with SEC-compliance and corporate governance matters, as well as Financial Industry Regulatory Authority (FINRA) issues.
Mr. Kiernan’s representative
transactions include advising:
- Israel Chemicals Ltd., a leading global specialty minerals and specialty chemicals company, on the US$1 billion sale of its fire safety and oil additives businesses to SK Capital Partners
- Cnova N.V. and its parent company Groupe Casino on its reorganization and spin-off of Groupe Casino's eCommerce businesses, by way of an US$188 million IPO on NASDAQ*
- The underwriters on the £405 million IPO of cyber security company Sophos PLC on the London Stock Exchange*
- The underwriters on the US$1.6 billion IPO and privatisation of Oil Refineries Ltd. on the Tel Aviv Stock Exchange pursuant to Rule 144A – the largest-ever IPO in Israel*
- Numerous Israeli and European technology and life sciences companies on SEC-registered IPOs on NASDAQ and the NYSE, including: Mediwound; Luxoft; Allot Communications; Evogene; Saifun; and Voltaire*
- The underwriters on numerous IPOs and secondary and follow-on offerings on NASDAQ and the NYSE by technology and life sciences companies, including: SodaStream; Magic Software; Sapiens; Lumenis; QIWI; Mellanox; MediaMind; Foamix; PowerDsine and Aladdin*
- B Communications on its US$800 million high yield bond offering - the first-ever international bond offering listed on the Tel Aviv Stock Exchange*
- The underwriters on the convertible bond offering by Audiocodes*
- Antargaz on its Rule 144A high yield bond offering*
- Viber Media on its US$900 million all-cash sale to Rakuten Inc.*
- Provigent on its US$350 million sale to Broadcom*
*matter handled prior to joining the firm